Min Yu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 52
- Lung Cancer Research Studies 15
- Pancreatic and Hepatic Oncology Research 13
- Cancer Immunotherapy and Biomarkers 12
Min Yu
115 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 136
- Cancer Research 628
- Oncology 745
- Immunology 352
- Hepatology 124
- Molecular Biology 950
Countries citing papers authored by Min Yu
This map shows the geographic impact of Min Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Yu more than expected).
Fields of papers citing papers by Min Yu
This network shows the impact of papers produced by Min Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Yu. The network helps show where Min Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 42 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 27 | |
| 15 | 2019 | 61 | |
| 16 | 2019 | 128 | |
| 17 | 2018 | 46 | |
| 18 | 2018 | 6 | |
| 19 | 2016 | 18 | |
| 20 | 2011 | 5 |
About Min Yu
Min Yu is a scholar working on Oncology, Cancer Research, Hepatology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 119 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (15 papers), Pancreatic and Hepatic Oncology Research (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), RNA modifications and cancer (9 papers), Lung Cancer Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Immunotherapy and Immune Responses (7 papers). The work is most often cited by research in Cancer Research (628 citations), Oncology (745 citations), Immunology (352 citations), Hepatology (124 citations) and Molecular Biology (950 citations). Min Yu has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Baohua Hou, Weifeng Hong, Renguo Guan, Ye Lin, Haosheng Jin, Guangzhe Zhao, Lei Tu, Zhixiang Jian, Yu Zhou and Zi Yin. Their work appears in journals such as Frontiers in Oncology, Investigational New Drugs, Scientific Reports, Annals of Translational Medicine and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.